Development and Validation of a Multiplex Microsphere Immunoassay Using Dried Blood Spots for SARS-CoV-2 Seroprevalence: Application in First Responders in Colorado, USA-Reference-Cited by-同舟云学术

Development and Validation of a Multiplex Microsphere Immunoassay Using Dried Blood Spots for SARS-CoV-2 Seroprevalence: Application in First Responders in Colorado, USA

Published:2021-05-19 Issue:6 Volume:59 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Schultz Jonathan S.¹^ORCID,McCarthy Mary K.²,Rester Cody²,Sabourin Katherine R.²,Annen Kyle³,DomBourian Melkon³,Eisenmesser Elan⁴,Frazer-Abel Ashley⁵,Knight Vijaya³,Jaenisch Thomas⁶,Morrison Thomas E.²,Rochford Rosemary²⁶,Kedl Ross M.²

Affiliation:

1. Division of Infectious Diseases, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA

2. Department of Immunology and Microbiology, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA

3. Clinical & Translational Allergy and Immunology Laboratory, Children’s Hospital of Colorado, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA

4. Department of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA

5. Exsera Biolabs, Department of Rheumatology, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA

6. Department of Epidemiology, Colorado School of Public Health, Anschutz Medical Campus, Aurora, Colorado, USA

Abstract

Serological testing of large representative populations for antibodies to SARS-CoV-2 is needed to estimate seroprevalence, transmission dynamics, and the duration of antibody responses from natural infection and vaccination. In this study, a high-throughput SARS-CoV-2 multiplex microsphere immunoassay (MMIA) was developed for the receptor binding domain (RBD) and nucleocapsid (N) that was more sensitive than enzyme-linked immunosorbent assay (ELISA) (98% versus 87%).

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00290-21

Reference51 articles.

1. Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020

2. Serosurveillance and the COVID-19 Epidemic in the US

3. What policy makers need to know about COVID-19 protective immunity

4. Prevalence of Asymptomatic SARS-CoV-2 Infection

5. Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patients with COVID-19: A prospective contact-tracing study

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innate and Adaptive Cell-Mediated Immune Responses to a COVID-19 mRNA Vaccine in Young Children;Open Forum Infectious Diseases;2023-12-01

2. Microparticle-Based Detection of Viruses;Biosensors;2023-08-15

3. An Overview of the Conventional and Novel Methods Employed for SARS-CoV-2 Neutralizing Antibody Measurement;Viruses;2023-07-05

4. Evidence for Aerosol Transfer of SARS-CoV-2–Specific Humoral Immunity;ImmunoHorizons;2023-05-01

5. Diagnostics and analysis of SARS-CoV-2: current status, recent advances, challenges and perspectives;Chemical Science;2023